Gibson Elena, Li Haojia, Staub Judith, Neklason Deb, Keener Megan, Kanth Priyanka
Division of Gastroenterology, University of Alabama at Birmingham, Birmingham, Alabama.
Division of Biostatistics, University of Utah, Salt Lake City, Utah.
Gastro Hep Adv. 2024 Jul 14;3(7):995-1000. doi: 10.1016/j.gastha.2024.07.004. eCollection 2024.
Lynch syndrome (LS) is caused by pathogenic mutations in mismatch repair (MMR) genes. There are limited data on differences in colorectal cancer (CRC) surveillance by MMR genes, and an international consensus on surveillance based on genes is not established. We aimed to evaluate colonoscopy and esophagogastroduodenoscopy (EGD) surveillance outcomes and compare CRC surveillance findings by the mutated gene.
One hundred one patients with LS were included and colonoscopy results were compared by MMR mutation. Primary outcomes included the development and recurrence of adenoma, CRC, high-grade dysplasia, advanced adenoma, and sessile serrated lesions. Logistic regressions evaluated the relationship between genes and the development or recurrence of primary outcomes. Survival analysis evaluated primary outcomes in patients with ≥ 2 colonoscopies. EGD results were summarized.
Three hundred twenty seven colonoscopies were reviewed. Compared to , was associated with a higher risk of advanced adenoma/high-grade dysplasia/CRC development (odds ratio [OR] 9.85, 95% confidence interval [CI]: 1.97-77.24) and was associated with a higher risk of adenoma development (OR 4.17, 95% CI: 1.11-17.61). Among those with > 2 colonoscopies, (hazard ratio 18.98, 95% CI: 1.31-274.51) and (hazard ratio 15.03, 95% CI: 1.16-194.65) had a higher risk of sessile serrated lesions compared to . Among patients who had adenoma detected once, had a higher risk of adenoma recurrence compared to (OR 14.59, 95% CI: 1.53-244.30) and (OR 47.15, 95% CI: 4.26-984.28). had a higher risk of adenoma recurrence compared to (OR 11.89, 95% CI: 1.38-164.78). Of 170 EGDs, an actionable finding was identified in 16% of patients during their first 3 EGDs.
Surveillance colonoscopy outcomes differed in patients with LS and suggest the need to guide surveillance based on MMR gene mutation.
林奇综合征(LS)由错配修复(MMR)基因的致病性突变引起。关于MMR基因在结直肠癌(CRC)监测方面差异的数据有限,且尚未建立基于基因的监测国际共识。我们旨在评估结肠镜检查和食管胃十二指肠镜检查(EGD)的监测结果,并比较不同突变基因的CRC监测结果。
纳入101例LS患者,根据MMR突变情况比较结肠镜检查结果。主要结局包括腺瘤、CRC、高级别异型增生、进展性腺瘤和无蒂锯齿状病变的发生与复发。逻辑回归评估基因与主要结局发生或复发之间的关系。生存分析评估接受≥2次结肠镜检查患者的主要结局。总结EGD结果。
共审查了327次结肠镜检查。与……相比,……与进展性腺瘤/高级别异型增生/CRC发生风险较高相关(比值比[OR]9.85,95%置信区间[CI]:1.97 - 77.24),……与腺瘤发生风险较高相关(OR 4.17,95% CI:1.11 - 17.61)。在接受>2次结肠镜检查的患者中,与……相比,……(风险比18.98,95% CI:1.31 - 274.51)和……(风险比15.03,95% CI:1.16 - 194.65)发生无蒂锯齿状病变的风险较高。在曾检测到腺瘤的患者中,与……相比,……腺瘤复发风险较高(OR 14.59,95% CI:1.53 - 244.30),与……相比也较高(OR 47.15,95% CI:4.26 - 984.28)。与……相比,……腺瘤复发风险较高(OR 11.89,95% CI:1.38 - 164.78)。在170次EGD检查中,16%的患者在最初3次EGD检查期间发现了可采取行动的检查结果。
LS患者的监测结肠镜检查结果存在差异,提示需要根据MMR基因突变指导监测。